Sarepta Will Resume US Elevidys Shipments For Ambulatory DMD Patients

Discussions On Non-Ambulatory Safety Ongoing

 
• By Mandy Jackson
  
The FDA recommended removing a voluntary hold on shipments of Elevidys to ambulatory DMD patients (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies